Shareholder Information

ExpreS2ion Biotechnologies have been listed on NASDAQ First North [EXPRS2] since 2016

Name Number of shares held Share of votes and capital
ExpreS2ion Holding ApS1 1.744.370 11,47%
AR Consult ApS2 1.397.003 9,19%
Försäkringsaktiebolaget, Avanza Pension 1.331.480 8,76%
Clearstream Banking S.A., W8IMY 858.540 5,65%
Summary shareholders over 5% 5.331.393 35,07%
Remaining shareholders (below 5%) 9.870.622 64,93%
Total 31/03/2020 15.202.015 100,00%

1. Chairman of the board Martin Roland Jensen holds 32.22% of the voting and capital shares in ExpreS2ion Holding ApS.
Co-Founder & Director, Cell Culture Charlotte Dyring owns 39.23% of the voting and capital shares in ExpreS2ion Holding ApS. Co-Founder & CSO Wian de Jongh owns 28.55% of the voting and capital shares in ExpreS2ion Holding ApS.

2. Board member Allan Rosetzsky owns 100% of the shares in AR Consult ApS
.

Certified Advisor

Svensk Kapitalmarknadsgranskning AB

Email: ca@skmg.se

Phone: +46 11 32 30 732

Web: www.skmg.se